Brucchi Francesco, De Troyer Annabelle, Sassun Richard, Dionigi Gianlorenzo, Muysoms Filip
General Surgery Residency Program, University of Milan, Milan, Italy.
Division of Surgery, Istituto Auxologico Italiano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
J Abdom Wall Surg. 2025 Jul 4;4:14723. doi: 10.3389/jaws.2025.14723. eCollection 2025.
This systematic review and meta-analysis compares robotic eTEP and TARM/TARUP in terms of complications, operative time, infections, length of stay, seroma, and short-term recurrence rates.
A systematic review was conducted following PRISMA guidelines, searching MEDLINE, Embase, and CENTRAL until January 30, 2025. Studies comparing r-eTEP and r-TARM/TARUP in adults with ventral hernia were included. Primary outcomes were operative time and postoperative complications. Secondary outcomes included wound complications, length of stay, readmission, pain, and short-term recurrence. A random-effects model was used for meta-analysis, and study quality was assessed via the Methodological Index for Non-randomised Studies (MINORS) score.
Three studies (308 patients: r-eTEP 176, r-TARM/TARUP 132) were included. Overall complications were lower with r-eTEP (RD: -0.17; 95% CI: -0.27 to -0.07; p = 0.001) and as was the case for minor complications (RD: -0.14; 95% CI: -0.22 to -0.06; p = 0.0008). No significant differences were found in major complications, SSI, recurrence, or 30-day readmission. Operative time was shorter with r-eTEP (MD: -25.66 min; 95% CI: -51.18 to -0.14; p = 0.05, I = 88%). Seroma formation was lower with r-eTEP (RD: -0.08; 95% CI: -0.15 to -0.02; p = 0.01). Length of stay was shorter with r-eTEP (MD: -2.64 days; 95% CI: -4.06 to -1.22; p = 0.004, I = 98%).
Evidence remains insufficient to favor one robotic approach over the other. High-quality prospective studies on patient outcomes and long-term recurrence are needed to guide surgical decision-making.
PROSPERO, identifier CRD420250650879.
本系统评价和荟萃分析比较了机器人辅助经腹腹膜前修补术(r-eTEP)和经腹网膜瓣修补术/经腹网膜瓣补片修补术(TARM/TARUP)在并发症、手术时间、感染、住院时间、血清肿和短期复发率方面的差异。
按照PRISMA指南进行系统评价,检索MEDLINE、Embase和CENTRAL数据库至2025年1月30日。纳入比较成人腹疝患者r-eTEP和r-TARM/TARUP的研究。主要结局为手术时间和术后并发症。次要结局包括伤口并发症、住院时间、再入院、疼痛和短期复发。采用随机效应模型进行荟萃分析,并通过非随机研究方法学指数(MINORS)评分评估研究质量。
纳入三项研究(308例患者:r-eTEP组176例,r-TARM/TARUP组132例)。r-eTEP组总体并发症较低(风险差:-0.17;95%置信区间:-0.27至-0.07;p = 0.001),轻微并发症情况相同(风险差:-0.14;95%置信区间:-0.22至-0.06;p = 0.0008)。在严重并发症、手术部位感染、复发或30天再入院方面未发现显著差异。r-eTEP组手术时间较短(平均差:-25.66分钟;95%置信区间:-51.18至-0.14;p = 0.05,I² = 88%)。r-eTEP组血清肿形成较低(风险差:-0.08;95%置信区间:-0.15至-0.02;p = 0.01)。r-eTEP组住院时间较短(平均差:-2.64天;95%置信区间:-4.06至-1.22;p = 0.004,I² = 98%)。
目前证据仍不足以表明一种机器人手术方法优于另一种。需要高质量的前瞻性研究来评估患者预后和长期复发情况,以指导手术决策。
PROSPERO,标识符CRD420250650879 。